AIM: To examine human beta-defensin-3 (hBD-3) expression in inflamed gastric mucosal tissues or MKN45 gastric cancer cells with or without H. pylori infection for better understanding the innate immune response to H. pylori. METHODS: We used reverse transcription-polymerase chain reactions and immunohistochemistry to examine hBD-3 expression in inflamed gastric mucosal tissues or MKN45 gastric cancer cells with or without H. pylori. Effects of hBD-3 against H. pylori were also evaluated. RESULTS: The mean mRNA expression of hBD-3 in H. pylori-positive specimens was significantly higher than that in H pylori-negative specimens (P = 0.0002, Mann-Whitney). In addition, unlike uninfected samples, 8 of 15 (53.33%) infected mucosal samples expressed hBD-3 protein. H. pylori dose-dependently induced mRNA expression of hBD-3 in MKN45 cells, an effect inhibited by adding anti-toll-like receptor (TLR)-4 antibody. HBD-3 protein completely inhibited H. pylori growth. CONCLUSION: Our results suggest that like hBD-2, hBD-3 may be involved in the pathophysiology of H. pylori-induced gastritis.
AIM: To examine humanbeta-defensin-3 (hBD-3) expression in inflamed gastric mucosal tissues or MKN45 gastric cancer cells with or without H. pylori infection for better understanding the innate immune response to H. pylori. METHODS: We used reverse transcription-polymerase chain reactions and immunohistochemistry to examine hBD-3 expression in inflamed gastric mucosal tissues or MKN45 gastric cancer cells with or without H. pylori. Effects of hBD-3 against H. pylori were also evaluated. RESULTS: The mean mRNA expression of hBD-3 in H. pylori-positive specimens was significantly higher than that in H pylori-negative specimens (P = 0.0002, Mann-Whitney). In addition, unlike uninfected samples, 8 of 15 (53.33%) infected mucosal samples expressed hBD-3 protein. H. pylori dose-dependently induced mRNA expression of hBD-3 in MKN45 cells, an effect inhibited by adding anti-toll-like receptor (TLR)-4 antibody. HBD-3 protein completely inhibited H. pylori growth. CONCLUSION: Our results suggest that like hBD-2, hBD-3 may be involved in the pathophysiology of H. pylori-induced gastritis.
Authors: J R García; A Krause; S Schulz; F J Rodríguez-Jiménez; E Klüver; K Adermann; U Forssmann; A Frimpong-Boateng; R Bals; W G Forssmann Journal: FASEB J Date: 2001-08 Impact factor: 5.191
Authors: A Wada; K Ogushi; T Kimura; H Hojo; N Mori; S Suzuki; A Kumatori; M Se; Y Nakahara; M Nakamura; J Moss; T Hirayama Journal: Cell Microbiol Date: 2001-02 Impact factor: 3.715
Authors: Y Hamanaka; M Nakashima; A Wada; M Ito; H Kurazono; H Hojo; Y Nakahara; S Kohno; T Hirayama; I Sekine Journal: Gut Date: 2001-10 Impact factor: 23.059
Authors: H Isomoto; Y Mizuta; M Miyazaki; F Takeshima; K Omagari; K Murase; T Nishiyama; K Inoue; I Murata; S Kohno Journal: Am J Gastroenterol Date: 2000-10 Impact factor: 10.864
Authors: A Wada; N Mori; K Oishi; H Hojo; Y Nakahara; Y Hamanaka; M Nagashima; I Sekine; K Ogushi; T Niidome; T Nagatake; J Moss; T Hirayama Journal: Biochem Biophys Res Commun Date: 1999-10-05 Impact factor: 3.575
Authors: Sabine Nuding; Michael Gersemann; Yoshio Hosaka; Sabrina Konietzny; Christian Schaefer; Julia Beisner; Bjoern O Schroeder; Maureen J Ostaff; Katunori Saigenji; German Ott; Martin Schaller; Eduard F Stange; Jan Wehkamp Journal: PLoS One Date: 2013-09-11 Impact factor: 3.240